Intrauterine Devices Market Analysis

Intrauterine Devices Market Analysis

Based on product, the intrauterine devices market is categorized into copper IUD and hormonal IUD. The hormonal IUD segment dominated the market with a revenue of around USD 2.3 billion in 2023.
 

• Hormonal IUDs release progestin which not only prevents pregnancy but also provides additional benefits such as reducing menstrual bleeding and cramps. This dual function makes them highly appealing to many women.
   
• Moreover, hormonal IUDs offer long-term protection ranging from 3 to 7 years, making them a convenient option for long-term contraception, and increased their demand in the market.
   

Based on age group segment, the intrauterine devices market is categorized into 15-19, 20-24, 25-29, 30-34, 35-39, 40-44, and 45+. The 30-34 age group segment held leading share in the market with a revenue of around USD 1.2 billion in 2023.
 

• Women in their mid-to-late twenties and thirties are often in stable relationships and may seek reliable contraception that is effective and easy to manage. Further, this age group also sees significant IUD adoption owing to increased awareness regarding healthy difference in age between two pregnancies.
   
• Moreover, healthcare providers often recommend IUDs to women in their 30s because they are highly effective and require less frequent medical intervention compared to other contraceptive methods.
   

Based on end-use, the intrauterine devices market is categorized into hospitals, gynecology clinics, and community health care centers. The hospital segment dominated the market with a revenue share of around 46.8% in 2023.
 

• Hospitals offer a broad spectrum of healthcare services under one roof, including gynecological care, family planning, and contraceptive services, making them a convenient choice for women seeking IUDs.
   
• Additionally, many health insurance plans are more likely to cover procedures performed in hospitals, making it financially easier for patients to access IUD services in these settings.
   

North America intrauterine devices market accounted for USD 1.5 billion revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
 

• Government and non-government organizations in the region have been conducting extensive awareness campaigns about the benefits and safety of IUDs. This has led to increased knowledge and acceptance among women.  
   
• Additionally, the high rate of unintended pregnancies in North America underscores the need for effective contraceptive methods. IUDs offer a reliable solution, leading to higher adoption rates.
   

The U.S. intrauterine devices market held majority market share and is anticipated to witness substantial growth, driven by numerous factors.
 

• Many health insurance plans in the U.S. cover the cost of IUDs, making them more accessible to a larger segment of the population.
   
• Furthermore, programs such as the Affordable Care Act (ACA) in the U.S. have mandated coverage for contraceptive methods, including IUDs, without additional out-of-pocket costs, contributing to their increased demand.
   

The intrauterine devices market in UK is expected to experience significant and promising growth from 2024 to 2032.
 

• Healthcare professionals in the UK often recommend IUDs for their effectiveness and convenience, influencing more women to choose this method.
   
• Additionally, the National Health Service (NHS) in the UK offers free IUDs as part of its contraceptive services. This makes IUDs accessible to a broad segment of the population, encouraging their use in the country.
   

Japan intrauterine devices market is anticipated to witness lucrative growth between 2024 – 2032.
 

• Many women in Japan are choosing to delay having children in favour of pursuing higher education and career opportunities, increasing the demand for long-term contraceptive methods.
   
• Furthermore, Japan's advanced healthcare infrastructure ensures that women have access to high-quality contraceptive services, including the latest IUD options.